LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its product portfolio consists of the LENSAR Laser System and ALLY Adaptive Cataract Treatment System (ALLY System) and its associated consumable components. The system incorporates a range of technologies designed to assist the surgeon in obtaining visual outcomes. The consumable portion of the system consists of a disposable patient interface device kit. The ALLY System is designed to combine its femtosecond laser technology features with enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room or in-office surgical suite. Its system is used across surgeons, hospital outpatient surgical facilities and ambulatory surgery centers.
Código da empresaLNSR
Nome da EmpresaLENSAR Inc
Data de listagemSep 21, 2020
CEOMr. Nicholas T. (Nick) Curtis
Número de funcionários140
Tipo de títulosOrdinary Share
Fim do ano fiscalSep 21
Endereço2800 Discovery Drive
CidadeORLANDO
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal32826
Telefone18885367271
Sitehttps://www.lensar.com/
Código da empresaLNSR
Data de listagemSep 21, 2020
CEOMr. Nicholas T. (Nick) Curtis
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.

Sem dados